Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,277 GBX | +0.24% | +3.81% | +6.53% |
10:50am | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
10:12am | AstraZeneca: Voydeya approved in the EU as a treatment for HPN | CF |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
885.2 DKK | +1.13% | +1.99% | 557B | ||
229.6 CHF | +1.71% | +3.66% | 200B | ||
88.55 EUR | +0.43% | +2.06% | 117B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.58% | 215B | |
+25.46% | 659B | |
+26.74% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+7.60% | 210B | |
-6.09% | 200B | |
-8.79% | 149B | |
-5.59% | 146B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Novo Nordisk hires AstraZeneca executive to revive struggling biopharma unit